Enhancement of tamoxifen-induced suppression of insulin-like growth factor I gene expression and serum level by a somatostatin analogue

Biochemical and Biophysical Research Communications

Volumn 203, Issue 1, 1994, Pages 253-259

  Huynh, Hung ^a   Pollak, Michael ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

OCTREOTIDE; SOMATOMEDIN C; SOMATOSTATIN DERIVATIVE; TAMOXIFEN;

ANIMAL EXPERIMENT; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; GENE REPRESSION; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMAL; BLOTTING, NORTHERN; COMPARATIVE STUDY; DRUG INTERACTIONS; FEMALE; GENE EXPRESSION; INSULIN-LIKE GROWTH FACTOR I; LIVER; OCTREOTIDE; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; TAMOXIFEN;

EID: 0028058649     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1006/bbrc.1994.2175     Document Type: Article

References (28)

1. Pollak M, Sem, AW, Richard M, et al. Jnci 84:966-971, 1992
2. Pollak M: Effects of Adjuvant Tamoxifen Therapy On Growth Hormone And Insulin-Like Growth Factor I (Igf-I) Physiology. In Adjuvant Therapy of Cancer 7 (Salmon Se, Ed). J. B. Lippincott Company, Pp 43-54, 1993
3. Friedl A, Jordan VC, Pollak M, Eur J Cancer 29a: 1368-1372, 1993
4. Cullen KJ, Yee D, Rosen N, Cancer Invest 9:443-454, 1991
5. Hursting SD, Switzer BR, French JE, Kari FW, Cancer Res 53:2750-2757, 1993
6. Pollak M, Polychronakos C, Guyda H, Anticancer Res 9:889-892, 1989
7. Pollak M, Costantino J, Polychronakos C, Et al., Jnci 82:1693-1697, 1990
8. Mcguire WI, Jackson JG, Figueroa JA, Et al., Jnci 84:1336-1341, 1992
9. Pietrzkowski Z, Wernicke D, Porcu P, Et al., Cancer Res 52:6447-6451, 1992
10. Pollak M, Richard M, Jnci 82:1349-1352, 1990
11. Trojan J, Rudin S, Tykocinski M, Johnson T, Ilan J, Science 259:94-97, 1993
12. Kiang DT, Kollander R, Kiang B, Et al., Proc Am Soc Clin Oncology 11:51, 1992
13. Reed MJ, Christodoulides A, Koistinen R, et al., Int J Cancer 52:208-212, 1992
14. Lien EA, Johannessen DC, Aakvaag A, Et al. J Steroid Biochem Mol Biol 41:541-543. 1992
15. Lonning PE, Hall K, Aakvaag A, et al., Cancer Res 52:4719-4723, 1992
16. Tannenbaum GS, Gurd W, Lapointe M, Et al, Endocrinolev 130:3395-3401, 1992
17. Malaab SA, Pollak M, Goodyer CG. Eur J Cancer 28a:788-793, 1992
18. Huynh HT, Tetenes E, Wallace L, Et al., Cancer Res 53:1727-1730, 1993
19. Bauer W, et al. Life Sci 31:1133-1140. 1982
20. Salmela PI, et al. J Clin Endo Met 70:1193-1201. 1990
21. Serri O, Brazeau P, Kachra Z, et al., Endocrinology 130:1816-1821, 1992
22. Weckbecker G, Liu R, Tolcsvai L, Et al. Cancer Res 52:4973-4978, 1992
23. Schally AV, Cancer Res. 48:6977-85, 1988
24. Schally AV, Redding TW. Proc Natl Acad Sci Usa 84:7275-9, 1987
25. Szepeshazi K, Milovanovics S, Lapis K, Groot K, Schally, AV. Breast Cancer Res. Tit. 21:181-92, 1992
26. Jordan VC, Jnci 82:1662-1663, 1990
27. Murphy LJ, Bell GI, Duckworth MI, et al., Endocrinology 121:684-691, 1987
28. Adams MD, Kelley JM, Gocayne JD, Et al., Science 252:1651-1656, 1991